
Celgene, Agios enter cancer metabolism deal
Executive Summary
Celgene Corp. and Agios Pharmaceuticals Inc. (oncology) will work together to develop and sell new therapeutics based on Agios's cancer metabolism platform.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Co-Promotion
- Includes Contract
- Includes Equity
- Includes Royalty or Profit Split Information
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com